J.O. Pharma Co.
A contract manufacturer established in 2003 that produces sterile prefilled syringe products. Operates automated filling and packaging lines under GMP, provides end-to-end manufacturing from solution preparation and sterile filtration to terminal sterilization, inspection, packaging and shipment. Holds ISO 14001 registration for environmental management and provides manufacturing services to pharmaceutical partners.
Industries
Nr. of Employees
medium (51-250)
Products
Prefilled saline syringes (5 mL, 10 mL, 20 mL)
Sterile prefilled syringes containing physiological saline in multiple syringe volumes for clinical and hospital use.
Prefilled heparin flush syringes (5 mL, 10 mL) and dialysis heparin syringes (20 mL)
Sterile prefilled syringes containing heparin formulations for line maintenance and dialysis applications.
Prefilled saline syringes (5 mL, 10 mL, 20 mL)
Sterile prefilled syringes containing physiological saline in multiple syringe volumes for clinical and hospital use.
Prefilled heparin flush syringes (5 mL, 10 mL) and dialysis heparin syringes (20 mL)
Sterile prefilled syringes containing heparin formulations for line maintenance and dialysis applications.
Services
On-site manufacturing service covering solution preparation, sterile filtration, automated filling, stopper application, terminal sterilization or aseptic processing, inspection, labeling, packaging and shipment for prefilled syringe products.
On-site manufacturing service covering solution preparation, sterile filtration, automated filling, stopper application, terminal sterilization or aseptic processing, inspection, labeling, packaging and shipment for prefilled syringe products.
Expertise Areas
- Prefilled syringe contract manufacturing
- Aseptic filling and terminal sterilization
- GMP quality assurance and batch release
- Process automation and production engineering
Key Technologies
- Prefilled syringe filling
- Automated aseptic filling lines
- Terminal wet‑heat autoclave sterilization
- Sterile filtration
News & Updates
Announcement regarding adoption of renewable-energy-derived electricity as part of decarbonization efforts.
Notice of changes in company executives.
Statement of participation in the UN Global Compact (published by group/affiliate information).
Announcement that the company website was renewed.
Notice regarding completion ceremony for the quality control building (facility expansion).
Announcement regarding adoption of renewable-energy-derived electricity as part of decarbonization efforts.
Notice of changes in company executives.
Statement of participation in the UN Global Compact (published by group/affiliate information).
Announcement that the company website was renewed.
Notice regarding completion ceremony for the quality control building (facility expansion).